|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/26 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 9/12 | (2006.01) |
| (11) | Number of the document | 3426284 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710231.6 |
| Date of filing the European patent application | 2017-03-10 | |
| (97) | Date of publication of the European application | 2019-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/055679 |
| Date | 2017-03-10 |
| (87) | Number | WO 2017/153575 |
| Date | 2017-09-14 |
| (30) | Number | Date | Country code |
| 201662306121 P | 2016-03-10 | US |
| (72) |
BEDNAREK, Maria, Aleksandra , GB
JERMUTUS, Lutz, Ulrich , GB
AMBERY, Philip , GB
PETRONE, Marcella , GB
|
| (73) |
MedImmune Limited ,
1 Francis Crick Avenue
Cambridge Biomedical Campus, Cambridge CB2 0AA,
GB
|
| (54) | GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS |
| GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS |